首站-论文投稿智能助手
典型文献
Reinfection and Breakthrough Infection of SARS-CoV-2: An Emerging Challenge That Is Threatening Our World
文献摘要:
The pandemic of coronavirus disease 2019 has threatened humans for more than one and a half years. In particular, viral mutation like delta strain has led to third- or fourth-wave transmission among the countries in Asia, Europe, and North America. Although large-scale vaccination has been carried out in many countries, the incidence of reinfection and vaccine-past breakthrough infection is becoming an emerging challenge to humans worldwide. The related mechanisms underlying the reinfection and breakthrough infection remain unknown. In this review, we summarized the challenge and related reasons for severe acute respiratory syndrome coronavirus 2 reinfection and breakthrough infection. Simultaneously, we addressed some critical contents of the study in future.
文献关键词:
Breakthrough infections;Reinfection;SARS-CoV-2;Vaccine
作者姓名:
Gao Lin;Mu Xiuying;Jiao Yan-Mei;Wang Fu-Sheng
作者机构:
Department of Infectious Diseases, The Fifth Medical Center of Chinese PLA General Hospital, National Clinical Research Center for Infectious Diseases, Beijing 100039, China;Peking University 302 Clinical Medical School, Beijing 100039, China;Department of Microbiology & Infectious Disease Center, School of Basic Medical Science, Peking University Health Science Center, Beijing 100191, China
引用格式:
[1]Gao Lin;Mu Xiuying;Jiao Yan-Mei;Wang Fu-Sheng-.Reinfection and Breakthrough Infection of SARS-CoV-2: An Emerging Challenge That Is Threatening Our World)[J].感染性疾病和免疫(英文),2022(01):29-33
A类:
Reinfection
B类:
Breakthrough,Infection,SARS,CoV,An,Emerging,Challenge,That,Is,Threatening,Our,World,pandemic,coronavirus,disease,has,threatened,humans,more,than,one,half,years,particular,viral,mutation,like,delta,strain,led,third,fourth,wave,transmission,among,countries,Asia,Europe,North,America,Although,large,scale,vaccination,been,carried,out,many,incidence,reinfection,vaccine,past,breakthrough,becoming,emerging,challenge,worldwide,related,mechanisms,underlying,remain,unknown,this,review,we,summarized,reasons,severe,acute,respiratory,syndrome,Simultaneously,addressed,some,critical,contents,study,future,infections,Vaccine
AB值:
0.680621
相似文献
Genomic Epidemiology of Imported Cases of COVID-19 in Guangdong Province, China, October 2020 – May 2021
LIANG Dan;WANG Tao;LI Jiao Jiao;GUAN Da Wei;ZHANG Guan Ting;LIANG Yu Feng;LI An An;HONG Wen Shan;WANG Li;CHEN Meng Lin;DENG Xiao Ling;CHEN Feng Juan;PAN Xing Fei;JIA Hong Ling;LEI Chun Liang;KE Chang Wen-Guangdong Provincial Key Laboratory of Virology,Institute of Medical Microbiology,Jinan University, Guangzhou 510632,Guangdong,China;Guangzhou National Laboratory,Guangzhou 510700,Guangdong, China;Guangdong Provincial Center for disease control and prevention,Guangdong Workstation for Emerging Infectious Disease Control and Prevention,Guangzhou 511430,Guangdong,China;Shantou University Medical College,Shantou 515041,Guangdong,China;Guangzhou Eighth People's Hospital,Guangzhou 510030, Guangdong,China;School of public health,Sun Yat-sen University,Guangzhou 510080,Guangdong,China;School of Public Health,Southern Medical University,Guangzhou 510515,Guangdong,China;Guangzhou Mendel Genomics and Medical Technology Co.,Ltd.,Guangzhou 510535,Guangdong,China;Department of Infectious Diseases,the Third Affiliated Hospital of Guangzhou Medical University,Guangzhou 510150, Guangdong,China;Department of Medical Biochemistry and Molecular Biology,School of Medicine,Jinan University,Guangzhou 510632,Guangdong,China
A trial of arbidol hydrochloride in adults with COVID-19
Zhao Jingya;Zhang Jinnong;Jin Yang;Tang Zhouping;Hu Ke;Sun Hui;Shi Mengmeng;Yang Qingyuan;Gu Peiyu;Guo Hongrong;Li Qi;Zhang Haiying;Li Chenghong;Yang Ming;Xiong Nian;Dong Xuan;Xu Juanjuan;Lin Fan;Wang Tao;Yang Chao;Huang Bo;Zhang Jingyi;Chen Shi;He Qiong;Zhou Min;Qu Jieming-Department of Pulmonary and Critical Care Medicine, Ruijin Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200025, China;Institute of Respiratory Diseases, School of Medicine, Shanghai Jiao Tong University, Shanghai 200025, China;Department of Emergency, Union Medical College Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430058, China;Department of Respiratory and Critical Care Medicine, Union Medical College Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430058, China;Department of Neurology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, China;Department of Respiratory and Critical Care Medicine, Renmin Hospital, Wuhan University, Wuhan, Hubei 430060, China;Department of Endocrinology, Union Medical College Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430058, China;Department of Respiratory Medicine, Wuhan Bauhinia Hospital, Wuhan, Hubei 430062, China;Department of Respiratory Medicine, Guanggu Hospital District, The Third Hospital of Wuhan, Wuhan, Hubei 430074, China;Department of Respiratory and Critical Care Medicine, Puren Hospital, Wuhan University of Science and Technology, Wuhan, Hubei 430081, China;Department of Respiratory Medicine, The Third People’s Hospital of Hubei Province, Wuhan, Hubei 430030, China;Department of Respiratory Medicine, The Sixth General Hospital of Hubei Province, Wuhan, Hubei 430015, China;Tuberculosis Department of Chengdu Public Health Clinical Medical Center, Chengdu, Sichuan 610066, China;Department of Neurology, Wuhan Red Cross Hospital, Wuhan, Hubei 430015, China;Department of Tuberculosis, Jinyintan Hospital, Wuhan, Hubei 430048, China;Department of Cardiology, The Third People’s Hospital of Hubei Province, Wuhan, Hubei 430030, China
Development and Validation of a Prognostic Risk Score System for COVID-19 Inpatients:A Multi-Center Retrospective Study in China
Ye Yuan;Chuan Sun;Xiuchuan Tang;Cheng Cheng;Laurent Mombaerts;Maolin Wang;Tao Hu;Chenyu Sun;Yuqi Guo;Xiuting Li;Hui Xu;Tongxin Ren;Yang Xiao;Yaru Xiao;Hongling Zhu;Honghan Wu;Kezhi Li;Churning Chen;Yingxia Liu;Zhichao Liang;Zhiguo Cao;Hai-Tao Zhang;Ioannis Ch.Paschaldis;Quanying Liu;Jorge Goncalves;Qiang Zhong;Li Yan-School of Artificial Intelligence and Automation,Huazhong University of Science and Technology,Wuhan 430074,China;School of Mechanical Science and Engineering,Huazhong University of Science and Technology,Wuhan 430074,China;Luxembourg Centre for Systems Biomedicine,University of Luxembourg,Belval L-4367,Luxembourg;Department of Emergency,Tongji Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430030,China;AMITA Health Saint Joseph Hospital Chicago,Chicago,IL 60657,USA;Department of Anesthesiology,Tongji Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430030,China;Huazhong University of Science and Technology-Wuxi Research Institute,Wuxi 214174,China;Division of Cardiology,Department of Internal Medicine,Tongji Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430030,China;Institute of Health Informatics,University College London,London NW1 2DA,UK;Department of Biomedical Engineering,Southern University of Science and Technology,Shenzhen 518055,China;Department of Infectious Diseases,Shenzhen Key Laboratory of Pathogenic Microbiology and Immunology,National Clinical Research Center for Infectious Disease,The Third People's Hospital of Shenzhen(Second Hospital Affiliated with the Southern University of Science and Technology),Shenzhen 518055,China;Department of Electrical and Computer Engineering&Division of Systems Engineering&Department of Biomedical Engineering,Boston University,Boston,MA 02215,USA;Department of Plant Sciences,University of Cambridge,Cambridge CB2 1TN,UK
A Vaccine Based on the Receptor-Binding Domain of the Spike Protein Expressed in Glycoengineered Pichia pastoris Targeting SARS-CoV-2 Stimulates Neutralizing and Protective Antibody Responses
Bo Liu;Ying Yin;Yuxiao Liu;Tiantian Wang;Peng Sun;Yangqin Ou;Xin Gong;Xuchen Hou;Jun Zhang;Hongguang Ren;Shiqiang Luo;Qian Ke;Yongming Yao;Junjie Xu;Jun Wu-Department of Microorganism Engineering,Beijing Institute of Biotechnology,Beijing 100071,China;Medical Innovation Research Division&Fourth Medical Center of the Chinese PLA General Hospital,Beijing 100853,China;Department of Neurosurgery,First Medical Center of the Chinese PLA General Hospital,Beijing 100853,China;Shenzhen Taihe Biotechnology Co.Ltd.,Shenzhen 518001,China;Institute of Physical Science and Information Technology,Anhui University,Hefei 230000,China
Potential Treatment of COVID-19 with Traditional Chinese Medicine:What Herbs Can Help Win the Battle with SARS-CoV-2?
Lin Li;Yuzheng Wu;Jiabao Wang;Huimin Yan;Jia Lu;Yu Wang;Boli Zhang;Junhua Zhang;Jian Yang;Xiaoying Wang;Min Zhang;Yue Li;Lin Miao;Han Zhang-State Key Laboratory of Component-Based Chinese Medicine,Tianjin University of Traditional Chinese Medicine,Tianjin 301617,China;Key Laboratory of Pharmacology of Traditional Chinese Medical Formulae,Ministry of Education,Tianjin University of Traditional Chinese Medicine,Tianjin 301617,China;Institute of Traditional Chinese Medicine,Tianjin University of Traditional Chinese Medicine,Tianjin 301617,China;Laboratory of Pharmacology of TCM Formulae Co-Constructed by the Province-Ministry,Tianjin University of Traditional Chinese Medicine,Tianjin 301617,China;School of Integrative Medicine,Tianjin University of Traditional Chinese Medicine,Tianjin 301617,China;Evidence-Based Medicine Center,Tianjin University of Traditional Chinese Medicine,Tianjin 301617,China;College of Traditional Chinese Medicine,Tianjin University of Traditional Chinese Medicine,Tianjin 301617,China
Nasal delivery of broadly neutralizing antibodies protects mice from lethal challenge with SARS-CoV-2 delta and omicron variants
Jia Lu;Qiangling Yin;Rongjuan Pei;Qiu Zhang;Yuanyuan Qu;Yongbing Pan;Lina Sun;Ding Gao;Cuiqin Liang;Jingwen Yang;Wei Wu;Jiandong Li;Zongqiang Cui;Zejun Wang;Xinguo Li;Dexin Li;Shiwen Wang;Kai Duan;Wuxiang Guan;Mifang Lian;Xiaoming Yang-National Engineering Technology Research Center for Combined Vaccines,Wuhan Institute of Biological Products Co.Ltd.,Wuhan,430070,China;State Key Laboratory for Molecular Virology and Genetic Engineering National Institute for Viral Disease Control and Prevention,Chinese Center for Disease Control and Prevention,Beijing,102206,China;Center for Emerging Infectious Diseases,Wuhan Institute of Virology,Chinese Academy of Sciences,Wuhan,430071,China;CDC-WIV Joint Research Center for Emerging Diseases and Biosafety,Wuhan,430071,China;Institution of Infectious Diseases,Shenzhen Bay Laboratory,Shenzhen,518107,China
Comparison of viral propagation and drug response among SARS-CoV-2 VOCs using replicons capable of recapitulating virion assembly and release
Lingqian Tian;Qiuhong Liu;Rongjuan Pei;Yingshan Chen;Chonghui Xu;Jielin Tang;Hao Sun;Kunpeng Liu;Qi Yang;Lei Yang;Leshan Li;Yongli Zhang;Yuan Zhou;Chao Shan;Xue Hu;Xinwen Chen;Yun Wang-State Key Laboratory of Virology,Wuhan Institute of Virology,Center for Biosafety Mega-Science,Chinese Academy of Sciences,Wuhan,430071,China;University of Chinese Academy of Sciences,Beijing 100049,China;Guangzhou Institutes of Biomedicine and Health,Chinese Academy of Sciences,Guangzhou,510530,China;Department of Gastroenterology,Guangzhou Women and Children's Medical Center,Guangzhou,510623,China;Innovation Center for Pathogen Research,Guangzhou Laboratory,Guangzhou,510320,China
SARS-CoV-2 infection induces testicular injury in Rhesus macaque
Mengying Liang;Wanbo Tai;Yunyun Wang;Yulong Dai;Yanfeng Yao;Juan Min;Yiwu Zhou;Liang Liu;Chao Shan;Han Xia;Zhiming Yuan-Key Laboratory of Special Pathogens and Biosafety,Wuhan Institute of Virology,Chinese Academy of Sciences,Wuhan,430061,China;University of Chinese Academy of Sciences,Beijing 100049,China;Institute of Infectious Diseases,Shenzhen Bay Laboratory,Shenzhen,518069,China;Department of Forensic Medicine,Tongji Medical College of Huazhong University of Science and Technology,Wuhan,430030,China;Wuhan National Biosafety Laboratory,Chinese Academy of Sciences,Wuhan,430073,China;The Core Facility and Technical Support,Wuhan Institute of Virology,Chinese Academy of Sciences,Wuhan,430061,China;State Key Laboratory of Virology,Wuhan Institute of Virology,Chinese Academy of Sciences,Wuhan,430061 China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。